Announcement

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…

Danielle Pillsbury2026 年 6 月 23 日

Poster

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…

Certara2026 年 6 月 22 日

Poster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…

Certara2026 年 6 月 22 日

Poster

Machine Learning based drug renal clearance predictor development and application

A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…

Certara2026 年 6 月 22 日

Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…

Certara2026 年 6 月 18 日

Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…

Certara2026 年 6 月 16 日

Webinar

Building IND-Ready and Investor-Ready Development Programs

Certara2026 年 6 月 15 日

Blog

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…

Certara2026 年 6 月 15 日

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

Certara2026 年 6 月 11 日

Blog

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…

Certara2026 年 6 月 11 日

建模与模拟

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Machine Learning based drug renal clearance predictor development and application

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Building IND-Ready and Investor-Ready Development Programs

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

2026 Simcyp Workshops

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

订阅时事通讯

快捷链接

解决方案

联系我们